FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

DATE RECALL INITIATED: April 2, 2004 LOT NUMBER / EXPIRATION DATE : X0667-2       6/24/2006 X0667-3       6/24/2006 W1419-2       12/6/2005 W1419-3       12/6/2005 MANUFACTURER: Aventis Pasteur Swiftwater, PA REASON: Aventis Pasteur is recalling four lots of Imovax Rabies, Rabies Vaccine (Human Diploid Cell) that were distributed in the U.S. This is a precautionary measure stemming from the discovery through routine testing of a non-inactivated production strain of virus in a single product lot, which was not distributed. As a special safeguard, Aventis Pasteur initiated the voluntary recall in the U.S. and abroad of distributed rabies vaccine lots produced during the same time period. The lots being recalled passed all release tests, including testing to confirm the absence of live virus. The firm is requesting that the use of these lots be immediately discontinued and returned to the manufacturer. The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

Updated April 2, 2004

CBER Home Page | CBER A-Z Index | CBER Search | Contact CBER FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page FDA / Center for Biologics Evaluation and Research